The global drug delivery solutions market is entering a period of steady expansion as healthcare providers, pharmaceutical companies, and other institutional buyers place greater emphasis on regulatory compliance, product standardization, replacement cycles, and procurement efficiency. According to Future Market Insights (FMI), the market is valued at USD 1.2 billion in 2026 and is projected to reach USD 2.1 billion by 2036, expanding at a 5.8% CAGR during the forecast period.
The market was valued at USD 1.1 billion in 2025. The forecast represents an incremental opportunity of USD 0.9 billion between 2026 and 2036.
Primary Packaging Solutions are expected to remain the leading product category, accounting for 52.0% of the market in 2026. Plastic is the leading material category with a 36.0% share. Injectable Drug Delivery remains the primary application area, supported by established consumption patterns and procurement structures.
Get detailed market forecasts, competitive benchmarking, and pricing trends:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14241
Regulatory Compliance Remains a Core Procurement Factor
Drug delivery solutions procurement is increasingly influenced by regulatory requirements across established and emerging healthcare markets. Product specification updates, labeling requirements, post-market surveillance obligations, and other compliance requirements are contributing to recurring procurement cycles.
FMI analysis also points to hospital and laboratory modernization as a structural source of demand. Aging installed bases across North America, Europe, and East Asia are creating replacement requirements as healthcare facilities update products and systems to meet changing safety, efficiency, and interoperability standards.
Cost containment is another consideration for institutional buyers. Procurement teams are increasingly assessing products based on per-procedure costs, clinical throughput, product performance, and total cost of ownership.
Nandini Roy Choudhury, Principal Consultant at FMI, says, “Companies that can align product portfolios with evolving regulatory requirements and institutional procurement standards are expected to strengthen market positioning through 2036.”
Primary Packaging Solutions Lead the Product Structure
Primary Packaging Solutions are forecast to account for 52.0% of the product segment in 2026. The category includes bottles, plastic bottles, glass bottles, vials, and ampoules.
Demand is concentrated across hospitals, clinics, laboratories, pharmaceutical companies, biotechnology companies, and contract manufacturing organizations. Procurement is influenced by clinical protocols, regulatory requirements, reimbursement conditions, and institutional purchasing cycles.
Blister Packaging represents another important growth category. Unit dose blisters, thermoformed blisters, and cold form blisters are gaining relevance as clinical applications expand across specialized and emerging use cases.
By material, Plastic leads with a 36.0% share. The material is used across a broad range of drug delivery applications and end-use settings.
China and India Stand Out Among High-Growth Markets
China is projected to record the fastest growth among the countries covered in the report, with a 7.5% CAGR through 2036. Centralized procurement through volume-based procurement programs and healthcare expansion in tier-2 and tier-3 cities are supporting market development.
India follows with a 6.9% CAGR. Expansion of Ayushman Bharat coverage and investment by private hospital chains are contributing to procurement demand.
Germany is forecast to grow at 6.4%, supported by healthcare infrastructure, EU MDR compliance requirements, hospital procurement structures, and domestic manufacturing capabilities.
Other country growth rates include Brazil at 5.8%, the USA at 5.2%, the UK at 4.7%, and Japan at 4.1%.
Competitive Environment
The competitive landscape includes Amcor Plc, SCHOTT AG, Gerresheimer AG, Berry Global Group Inc., Mondi Plc, Sealed Air Corp., Wipak Group, Constantia Flexibles, Ardagh Group SA, and Sonoco Products Company.
Amcor Plc leads the market through established manufacturing infrastructure, regulatory approval capabilities, broad product portfolios, and procurement relationships. SCHOTT AG maintains a competitive position through product specialization and diagnostic technology capabilities.
Other companies are competing through product performance, regulatory compliance, clinical evidence, geographic coverage, and specialized application capabilities.
Market Scope
FMI’s drug delivery solutions market assessment covers product, material, application, end use, distribution channel, and regional markets.
Products covered include Primary Packaging Solutions, Blister Packaging, Flexible Packaging, Advanced Drug Delivery Containers, and Caps and Closures. Materials include Plastic, Glass, Metal, and Paper and Paperboard.
Applications covered include Injectable Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, and Dermal and Transdermal Delivery.
The study covers North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and the Middle East and Africa. More than 30 countries are included, with specific analysis of the USA, China, India, Germany, Brazil, the UK, and Japan.
Discover the Full Details in Our Report—Read More Now!
https://www.futuremarketinsights.com/reports/drug-delivery-solutions-market
FMI Custom Research: Strategic Intelligence for Confident Decision-Making
In today’s rapidly evolving business environment, leadership teams need more than market data—they need clear, actionable intelligence tailored to their strategic objectives. FMI’s Custom Research solutions are designed around the specific business questions organizations need answered, enabling executives to evaluate growth opportunities, validate investments, assess competitive dynamics, and reduce uncertainty before making critical decisions. By combining deep industry expertise, primary research, and proprietary market intelligence, FMI delivers insights that help organizations move from assumptions to evidence-based strategies with greater speed and confidence.
Business Impact
FMI helps organizations transform market complexity into strategic clarity, enabling leadership teams to identify growth opportunities faster, optimize resource allocation, strengthen competitive positioning, and make high-stakes business decisions with confidence.
To explore how FMI Custom Research can support your strategic priorities, please connect with our team at – [email protected]
About Future Market Insights (FMI)
Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.
